Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tyra Biosciences Inc (“Tyra” or “the Company”) (NASDAQ: TYRA). Investors who purchased Tyra securities are encouraged to obtain additional information and assist the investigation.
Investigation Details:
The investigation concerns whether Tyra and certain of its officers and/or directors have engaged in corporate wrongdoing.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Tyra securities, you can assist this investigation. You can also contact Peretz Bronstein or his paralegal, Nathan Miller of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
TYRA — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”